Genmab Completes $1.8 Billion Acquisition of ProfoundBio, Secures Rights to Promising Cancer Treatments

Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash Acquisition gives Genmab worldwide rights to three candidates in clini...

May 22, 2024 | Wednesday | News
OSE Immunotherapeutics and Boehringer Ingelheim Broaden Partnership to Include New CRM and Cancer Therapies

OSE Immunotherapeutics and Boehringer Ingelheim announced a major expansion of their partnership. Two new projects to develop first-in-class treatments wi...

May 22, 2024 | Wednesday | News
Sanofi, Formation Bio, and OpenAI Forge Pioneering Partnership to Transform Drug Development with AI

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more eff...

May 21, 2024 | Tuesday | News
Xcell Biosciences Inc. and AmplifyBio Forge Alliance to Transform Engineered TCR Therapy Manufacturing

Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly ...

May 20, 2024 | Monday | News
Donaldson and PolyPeptide Partner to Pioneer Environmentally Friendly Solution for Peptide Manufacturing

Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and PolyPeptide Group...

May 14, 2024 | Tuesday | News
FogPharma® and ARTBIO Announce Collaboration to Develop Next-Generation Cancer Therapies

FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently availabl...

May 14, 2024 | Tuesday | News
Siren Biotech & Catalent Inc. Partner for Cancer Gene Therapy

Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., the leader in enabling the development and supply of bett...

May 09, 2024 | Thursday | News
Sciwind Biosciences and HK inno.N Partner to Advance Ecnoglutide for Diabetes and Obesity in South Korea

Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...

May 07, 2024 | Tuesday | News
Astellas Pharma and Poseida Therapeutics Forge Research Collaboration to Develop Novel CAR-T Cell Therapies for Solid Tumors

Astellas Pharma  and Poseida Therapeutics, Inc.   announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos")...

May 02, 2024 | Thursday | News
Beacon Biosignals & Takeda Forge Partnership to Elevate Sleep Disorder Biomarkers

Beacon Biosignals, the leader in at-home EEG and computational neurodiagnostics, announced a collaboration with Takeda to conduct at-home sleep monitoring ...

May 01, 2024 | Wednesday | News
ARS Pharmaceuticals Advances neffy® MAA with CHMP Response, Inks CSL Seqirus Deal for Australia & New Zealand

CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by...

May 01, 2024 | Wednesday | News
Biomerica and UAE's Healthcare Giant Ink Pioneering Deal for Advanced Cancer Screening Technologies

Biomerica Inc. , a global leader in innovative medical diagnostics, proudly announces a landmark multi-year exclusive distribution agreement with one of th...

April 30, 2024 | Tuesday | News
Multiply Labs and GenScript Transform Cell Therapy Manufacturing Through Automation

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corpor...

April 26, 2024 | Friday | News
BioArctic and Eisai Collaborate on Next-Generation Alzheimer's Treatment with BAN2802 Research Evaluation Agreement

BioArctic AB (publ) announced that BioArctic AB and Eisai Co., Ltd., have entered into a research evaluation agreement regarding BAN2802, a potential new t...

April 22, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in